Tofersen and the Future of ALS Drug Development
27:23
FDA Advisory Committee to Consider Tofersen
58:05
Antisense Oligonucleotide Therapy for ALS
15:22
Can we stop MS and ALS? | Michael C. Levin | TEDxUniversityofSaskatchewan
1:31:31
How to Slow ALS Progression
53:59
NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study
1:55:27
Worst Fails of the Year | Try Not to Laugh 💩
19:03
Introduction to Module 6 with Dr. William Zamboni
10:32